Alibhlinftecunspadr Stock Revenue
| TWYA Stock | EUR 12.40 0.40 3.33% |
ALIBHLINFTECUNSPADR fundamentals help investors to digest information that contributes to ALIBHLINFTECUNSPADR's financial success or failures. It also enables traders to predict the movement of ALIBHLINFTECUNSPADR Stock. The fundamental analysis module provides a way to measure ALIBHLINFTECUNSPADR's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ALIBHLINFTECUNSPADR stock.
ALIBHLINFTECUNSPADR |
ALIBHLINFTECUNSPADR Company Revenue Analysis
ALIBHLINFTECUNSPADR's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current ALIBHLINFTECUNSPADR Revenue | 22.72 B |
Most of ALIBHLINFTECUNSPADR's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ALIBHLINFTECUNSPADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, ALIBHLINFTECUNSPADR reported 22.72 B of revenue. This is 197.9% higher than that of the Healthcare sector and significantly higher than that of the Pharmaceutical Retailers industry. The revenue for all Germany stocks is 140.81% lower than that of the firm.
ALIBHLINFTECUNSPADR Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ALIBHLINFTECUNSPADR's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ALIBHLINFTECUNSPADR could also be used in its relative valuation, which is a method of valuing ALIBHLINFTECUNSPADR by comparing valuation metrics of similar companies.ALIBHLINFTECUNSPADR is rated fourth in revenue category among its peers.
ALIBHLINFTECUNSPADR Fundamentals
| Return On Equity | 0.0088 | |||
| Return On Asset | -0.0168 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | (0.02) % | |||
| Shares Outstanding | 676.01 M | |||
| Revenue | 22.72 B | |||
| Gross Profit | 4.11 B | |||
| EBITDA | (505.28 M) | |||
| Net Income | 348.59 M | |||
| Cash And Equivalents | 11.64 B | |||
| Cash Per Share | 17.30 X | |||
| Total Debt | 37.74 M | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 4.18 X | |||
| Book Value Per Share | 22.12 X | |||
| Cash Flow From Operations | 1.01 B | |||
| Earnings Per Share | 0.02 X | |||
| Number Of Employees | 1.58 K | |||
| Beta | 1.01 | |||
| Market Capitalization | 10.11 B |
About ALIBHLINFTECUNSPADR Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ALIBHLINFTECUNSPADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ALIBHLINFTECUNSPADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ALIBHLINFTECUNSPADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in ALIBHLINFTECUNSPADR Stock
ALIBHLINFTECUNSPADR financial ratios help investors to determine whether ALIBHLINFTECUNSPADR Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALIBHLINFTECUNSPADR with respect to the benefits of owning ALIBHLINFTECUNSPADR security.